Comparative Pharmacology
Head-to-head clinical analysis: ASPARLAS versus XIAFLEX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ASPARLAS versus XIAFLEX.
ASPARLAS vs XIAFLEX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Asparaginase (ASPARLAS) hydrolyzes L-asparagine to L-aspartic acid and ammonia, depleting circulating asparagine. Leukemic cells with low asparagine synthetase activity rely on exogenous asparagine; depletion inhibits protein and nucleic acid synthesis, leading to cell death.
XIAFLEX (collagenase clostridium histolyticum) is a combination of two collagenases (AUX-I and AUX-II) that hydrolyze collagen in the extracellular matrix. It targets type I and type III collagen, leading to enzymatic disruption of collagen-rich structures such as Dupuytren's cords and Peyronie's plaques.
Intravenous (IV) or intramuscular (IM) injection: 2,500 IU/m² every 14 days as a component of multi-agent chemotherapy. Administer IV over 1-2 hours in 100 mL of 0.9% sodium chloride.
0.58 mg injected directly into the palpable cord, up to 3 injections per treatment session (one per affected cord) at intervals of 1–2 days apart; repeated every 4 weeks as needed, up to 3 treatment sessions per cord.
None Documented
None Documented
The terminal elimination half-life is approximately 25.7 days (range 17.8–33.6 days) in children and 22.0 days in adults, allowing for dosing every 2 weeks instead of 3 times per week as with native E. coli asparaginase.
Systemic half-life not applicable due to minimal systemic absorption. Locally, collagenase activity declines within 1-2 days post-injection.
Calaspargase pegol (ASPARLAS) is eliminated via the reticuloendothelial system; renal excretion is negligible (<2% unchanged), and biliary/fecal excretion has not been quantified. The pegylated asparaginase is cleared through proteolytic degradation.
Primarily metabolized locally; systemic absorption minimal. No renal or biliary excretion data available; eliminated via local degradation.
Category C
Category C
Antineoplastic, Enzyme
Enzyme